Tcr2 Therapeutics Inc (TCRR) Financials

$1.48

$0.00 (0.00%)

As on 01-Jun-2023 09:30EDT

Market cap

$58 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Operating Expenses	131.88	123.08	99.74	68.70	51.38	26.45
Operating Profit (EBIT)	-165.80	-153.50	-99.74	-68.70	-51.38	-26.45
Other Income	1.41	1.94	0.22	1.74	3.89	--
Profit before Tax	-162.87	-151.56	-99.52	-66.96	-47.50	-24.25
Provision for Tax	0.23	0.26	0.29	0.16	0.10	--
Profit after Tax (Net Income)	-163.10	-151.82	-99.81	-67.12	-47.60	-24.25
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-102.59	-151.82	-99.81	-67.12	-97.50	-61.55

Liabilities ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	101.33	140.86	281.48	236.55	160.45	-85.70
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	2.71	3.32	23.29	0.81	0.55	209.66
Current Liabilities	47.47	64.06	18.61	8.84	7.53	5.47
Total Liabilities	198.99	208.24	323.37	246.20	168.53	129.43

Assets ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	11.02	30.62	47.24	10.66	5.34	3.94
Current Assets	140.49	177.62	276.13	235.54	163.19	125.49
Total Assets	198.99	208.24	323.37	246.20	168.53	129.43
Total Debt*	5.98	53.76	26.36	--	--	--
Net Current Assets	93.02	113.56	257.52	226.70	155.65	120.03

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-101.46	-81.60	-56.74	-41.36	-18.78
Cash Flow from Investing Activities	--	-88.49	78.45	-48.94	-20.42	-76.34
Cash from Financing Activities	--	0.13	132.14	134.70	79.52	122.98
Net Cash Inflow / Outflow	--	-189.82	128.98	29.03	17.75	--

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	-4.18	-3.89	-2.63	-2.40	-2.27	-24.25
Cash EPS ($)	--	-3.81	-2.55	-2.34	-2.23	-23.83
Adjusted Book Value ($)	--	3.61	7.41	8.45	7.64	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-2.60	-2.15	-2.03	-1.97	-18.78
Free Cash Flow per Share ($)	--	-3.00	-2.45	-2.28	-2.15	-19.80

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	-60.43	-36.67	-33.82	-127.35	43.30
ROE (%)	-111.47	-71.90	-38.53	-33.82	-127.35	43.30
ROA (%)	-58.98	-57.12	-35.05	-32.37	-31.95	-32.02
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	-11,575.51	-7,833.95	-44,556.70	-3,864.36	-1,225.20	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	-54.60	-53.90	-45.18	-33.70	-111.88	-85.55
Net Profit Growth (%)	-55.60	-52.12	-48.69	-41.02	-96.28	-85.55
EPS Growth (%)	-48.98	-0.48	-0.10	-0.06	0.91	--
Book Value Growth (%)	-60.31	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	--	-0.26	-1.77	-12.90	-6.30	--
Price / Book Value	0.22	0.28	0.63	3.66	1.87	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.63	0.63	0.64	-9.51	-2.81	--
Close Price ($)	1.50	1.00	4.66	30.93	14.28	--
High Price ($)	3.88	4.90	35.10	35.86	25.47	--
Low Price ($)	0.82	0.82	4.52	5.84	10.04	--
Market Cap ($ Cr)	58.11	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	--	0.38	0.09	--	--	--
Short term debt to equity ratio	0.03	0.36	0.01	--	--	--
Current Ratio	2.96	2.77	14.84	26.64	21.66	22.96
Quick Ratio	2.96	--	--	--	--	--
Interest Coverage	-18.88	-2.61	-445.28	-39.55	-13.23	--

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.